Home

Fulgent Genetics, Inc. (FLGT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Fulgent Genetics, Inc. (FLGT)

Go deeper and ask any question about FLGT

Company Performance

Current Price

as of Sep 13, 2024

$22.35

P/E Ratio

N/A

Market Cap

$677.13M

Description

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

Metrics

Overview

  • HQEl Monte, CA
  • SectorHealth Services
  • IndustryMedical/Nursing Services
  • TickerFLGT
  • Price$22.35+1.54%

Trading Information

  • Market Cap$677.13M
  • Float65.14%
  • Average Daily Volume (1m)112,553
  • Average Daily Volume (3m)179,674
  • EPS-$5.48

Company

  • Revenue$290.71M
  • Rev Growth (1yr)4.68%
  • Net Income-$8.71M
  • Gross Margin34.49%
  • EBITDA Margin-17.95%
  • EBITDA-$12.75M
  • EV$288.49M
  • EV/Revenue0.99
  • P/EN/A
  • P/S2.31
Documents